On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...